Belgium-based Sunrise, the developer of a chin patch home sleep test, has acquired sleep telemedicine provider Dreem Health, allowing Sunrise to offer not only sleep diagnostics but also treat sleep issues.

“Ensuring everyone has access to sleep medicine means moving past diagnosis, to reshape the entire patient experience,” says Laurent Martinot, CEO of Sunrise, in a release. “While the conversation around sleep health is growing, there’s been a shortage of practical, tech-driven solutions. Combining Sunrise’s technologies with Dreem Health’s telemedicine platform makes this possible. It offers accessible tools for diagnosis and treatment to everyone, no matter where they are. For our team, that’s what it’s all about—being there for our patients every step of the way.” 

With this acquisition, Sunrise strengthens its US presence. Based in California, Dreem Health’s partnerships with insurers like Aetna and United Healthcare ensure convenient, insured care. Alongside Sunrise’s FDA-approved technologies, this integration grants both patients and healthcare providers access to the newest technological advancements.

Sunrise launched its chin patch home sleep test in the United States last year after receiving US Food and Drug Administration clearance for its second-generation device and closing a €17 million ($18.2 million) funding round. 

The Sunrise sensor measures six signals including airflow from the nose and mouth, mandibular jaw movements (via an accelerometer and gyroscope), pulse rate, SpO2, and head position to detect sleep apnea.

Photo 118240905 © Miriam Doerr |